Collegium Pharmaceutical, Inc.
COLL
$28.23
$0.080.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -225.60% | 499.75% | 35.31% | 237.51% | -38.88% |
| Total Depreciation and Amortization | 14.41% | -1.11% | -0.21% | 35.35% | 59.61% |
| Total Amortization of Deferred Charges | -20.15% | -40.09% | -10.39% | 11.18% | -15.52% |
| Total Other Non-Cash Items | -17.16% | -9.67% | 652.98% | -190.62% | -35.41% |
| Change in Net Operating Assets | 331.99% | -51.88% | 101.27% | 86.70% | -164.50% |
| Cash from Operations | -1.54% | 3.10% | 45.37% | 971.63% | 7.48% |
| Capital Expenditure | -663.08% | 66.17% | -20.88% | 22.95% | 75.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5,479.23% | 121.36% | -73.16% | -263.03% | 67.00% |
| Cash from Investing | -17,141.54% | 116.81% | -70.63% | 87.60% | 67.27% |
| Total Debt Issued | -- | -- | 4,679.49% | -- | -- |
| Total Debt Repaid | 55.10% | 55.10% | -3,536.32% | 90.19% | 79.58% |
| Issuance of Common Stock | 56.17% | -34.84% | 469.36% | 269.68% | -94.61% |
| Repurchase of Common Stock | 97.47% | -45.69% | 96.60% | -578.87% | 37.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | 703.86% | 15.43% | 47.14% | -109.94% | 57.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -757.93% | 82.59% | 156.79% | 130.07% | 137.97% |